In general, I recommend the Samsung Galaxy Tab S9 as the best Samsung tablet for most folks because it's a flagship Galaxy tablet that delivers great performance, good battery life and a lovely ...

If you’re familiar with last year’s Galaxy Tab S9 lineup, you won’t find too many surprises in the new Galaxy Tab S10 models. The Galaxy Tab S10 Ultra and Tab S10 Plus feature the same high ...

Google is rolling out some new Chrome memory management features aimed at helping you wrangle out-of-control tabs more easily. The updates include new “Performance issue alerts” and some ...

The Samsung Galaxy Tab S10 Ultra is an incremental upgrade compared to the S9 Ultra and even the S8 Ultra, but it still has the biggest, best tablet screen on the block for watching widescreen content ...

A favorable safety and tolerability profile continued for both Duravyu arms. The 2.7mg dose is also being evaluated in the Phase 3 pivotal trials for wet AMD. The company said it expects to report the ...

Credit: fcm82 / Shutterstock. On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral glucagon-like peptide-1 receptor (GLP-1R) agonist, Rybelsus, which is ...

Bernstein said Novo Nordisk’s (NVO) recently released SOUL study results for Rybelsus in the reduction of major cardiovascular events in diabetic patients were modest and not as robust as ...

Please note that NVO already markets oral semaglutide in the United States under the brand name Rybelsus. It is administered once daily and comes in three approved doses, 3 mg, 7 mg and 14 mg.

Oral semaglutide (Rybelsus) lowered the risk for major adverse cardiovascular events (MACEs) by a significant 14% compared with placebo, Novo Nordisk announced. The topline results met the primary ...

Novo Nordisk’s Rybelsus is an oral semaglutide, approved for treating type 2 diabetes. Image credit: JHVEPhoto / Shutterstock. Novo Nordisk plans to file a label expansion for Rybelsus (oral ...